Windlas Biotech News and Updates

Name: Latest research reports of Windlas Biotech Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Windlas Biotech Ltd.
Rating: 3
Author: Prabhudas Lilladhar

Keep track of all breaking news on Windlas Biotech from all sources in a single place.

Load latest

Windlas Biotech Ltd.

05 Aug 2021

785.85

0.72%

Subscribe to Windlas Biotech: Prabhudas Lilladher

Moneycontrol

Prabhudas Lilladher has come out with its report on Windlas Biotech. The research firm has recommended to ''Subscribe'' the ipo in its research report as on August 05, 2021.

Windlas Biotech Ltd. is trading below all available SMAs

Subscribe to Windlas Biotech: Hem Securities

Moneycontrol | 05 Aug 2021

Windlas Biotech Ltd.

05 Aug 2021

785.85

0.72%

IPO Note - Direct play on CMO offers alternative opportunity for investors - SUBSCRIBE

IPO Note: Windlas Biotech Ltd.

Prabhudas Lilladhar

experience in manufacturing (solid/ liquid) multiple dosage offers a comprehensive range of CDMO services in India. Over time Windlas evolved and 6) strong financial performance with experienced management. It owns...

Windlas Biotech Ltd. is trading below all available SMAs

Windlas Biotech Ltd.

04 Aug 2021

785.85

0.72%

Windlas Biotech offers its shares at 64x PE. Should you subscribe?

Economic Times

The Dehradun-based firm will raise Rs 165 crore through issuance of fresh equity shares, while the promoters and existing shareholders will offload 51,42,067 equity shares worth Rs 236 crore via an offer-for-sale (OFS).

Windlas Biotech has lost -16.89% in the last 1 Month

Subscribe to Windlas Biotech: Choice Equity Broking

Moneycontrol | 03 Aug 2021, 11:50PM 1 more

Windlas Biotech Ltd.

04 Aug 2021, 12:00AM

785.85

0.72%

Windlas Biotech Ltd. IPO Note

IPO Note: Windlas Biotech Ltd.

Ashika Research

5 each, (Comprising of fresh issue of 3,586,957 Equity Shares* (Rs. 165 cr.) and Offer for Sale of 5,142,067 Equity Shares (Rs. 236.5 cr.*) by Selling Shareholder)....

Windlas Biotech has lost -16.89% in the last 1 Month

Windlas Biotech Ltd.

03 Aug 2021, 12:00AM

785.85

0.72%

Windlas Biotech Limited

IPO Subscribe: Windlas Biotech Ltd.

Angel Broking

Windlas Biotech Ltd. The company was incorporated in 2001 based in Dehradun. The Company operating with 3 business verticals 1. CDMO Products and services, 2. Domestic trade generics and Over-the-counter (OTC) market 3. Exports. The company currently owns and operates four manufacturing facilities located at Dehradun in Uttarakhand. As of March 31, 2021, their

Windlas Biotech has lost -16.89% in the last 1 Month

Windlas Biotech Ltd.

03 Aug 2021, 12:00AM

785.85

0.72%

Windlas Biotech Ltd : IPO

IPO Note: Windlas Biotech Ltd.

ICICI Securities Limited

Leading player in fast growing CDMO market With increasing globalisation and focus of large pharmaceutical players on cutting costs and optimising operations, CDMOs have seen significant acceptance in the pharmaceutical industry internationally over the last few years. The domestic formulations CDMO market has grown at a higher rate of ~13% compared to ~8.6% growth of the domestic formulations market (in terms of consumption) in the past five years. The company believe this increasing use of outsourcing by pharmaceutical companies for launch of...

Windlas Biotech has lost -30.08% in the last 1 Year

VOTE: Is Windlas Biotech Ltd. worth buying?

69 Votes:

Buy 85.51%

Sell 11.59%

Hold 2.9%

33.34% Fall from 52W High

Windlas Biotech News and Updates

Keep track of all breaking news on Windlas Biotech from all sources in a single place.